MORROW GEORGE J Insider Trades

Insider Trading History

Track insider trading activity for MORROW GEORGE J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $442k 2,567 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 2,567 shares
$155.83
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $1.79M 10,386 shares
Last Trade
May 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$516k 3,318 shares
$155.50
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$516k 3,318 shares
$155.50
$172.04
Align Technology
Align Technology ALGN
Director
Holding Value $899k 5,036 shares
Last Trade
May 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$285k 1,745 shares
$163.42
$178.46
Align Technology
Align Technology ALGN
Director
Holding Value $0 0 shares
Last Trade
May 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$285k 1,745 shares
$163.42
$178.46
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $3.8M 22,068 shares
Last Trade
Nov 25, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.15M 15,000 shares
$143.53
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $1.22M 7,068 shares
Last Trade
Nov 25, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.15M 15,000 shares
$143.37
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
Nov 25, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.15M 15,000 shares
$143.53
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 22, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$342k 2,869 shares
$119.12
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $1.22M 7,068 shares
Last Trade
May 22, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$342k 2,869 shares
$119.12
$172.04
Align Technology
Align Technology ALGN
Director
Holding Value $0 0 shares
Last Trade
May 21, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$197k 1,148 shares
$171.91
$178.46
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $571k 3,318 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 3,318 shares
$120.56
$172.04
Align Technology
Align Technology ALGN
Director
Holding Value $311k 1,745 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 1,745 shares
$171.91
$178.46
Align Technology
Align Technology ALGN
Director
Holding Value $587k 3,291 shares
Last Trade
May 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$197k 1,148 shares
$171.91
$178.46
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $494k 2,869 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 2,869 shares
$139.43
$172.04
Align Technology
Align Technology ALGN
Director
Holding Value $205k 1,148 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 1,148 shares
$261.12
$178.46
Align Technology
Align Technology ALGN
Director
Holding Value $382k 2,143 shares
Last Trade
May 17, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$279k 1,029 shares
$271.50
$178.46
Align Technology
Align Technology ALGN
Director
Holding Value $0 0 shares
Last Trade
May 17, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$279k 1,029 shares
$271.50
$178.46
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 17, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$597k 4,199 shares
$142.29
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $722k 4,199 shares
Last Trade
May 17, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$597k 4,199 shares
$142.29
$172.04

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up